Table 3 Longitudinal changes in the exudative PNV group according to the treatment patterns.
From: The implications of subretinal fluid in pachychoroid neovasculopathy
Parameters | Total exudative PNV (n = 26) | Anti-VEGF (n = 17) | Anti-VEGF + PDT (n = 4) | PDT (n = 2) | Observation (n = 3) |
|---|---|---|---|---|---|
BCVA, logMAR | |||||
Baseline | 0.23 ± 0.21 | 0.22 ± 0.23 | 0.29 ± 0.18 | 0.02 ± 0.03 | 0.30 ± 0.35 |
Latest follow up | 0.15 ± 0.20 | 0.15 ± 0.21 | 0.14 ± 0.11 | 0.03 ± 0.04 | 0.32 ± 0.33 |
P value* | 0.043 | 0.105 | 0.068 | 0.317 | 0.109 |
SRF status compared with baseline, n (%) | |||||
Complete absorption | 13 (50.0) | 7 (41.2) | 4 (100) | 0 (0) | 2 (66.7) |
Decreasing | 9 (34.6) | 9 (52.9) | 0 (0) | 0 (0) | 0 (0) |
Stationary or increasing | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Wax and wane | 4 (15.4) | 1 (5.9) | 0 (0) | 2 (100) | 1 (33.3) |
P value† | 0.006 | ||||
